Clinical Trial Update: Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating adalimumab's effect on vascular inflammation in psoriasis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Psoriasis
• Vascular Inflammation

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Psoriasis, Vascular Inflammation | Phase 4 | Status: COMPLETED